Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
+$378M |
| 2 |
AT&T
T
|
+$328M |
| 3 |
Roku
ROKU
|
+$326M |
| 4 |
Qualcomm
QCOM
|
+$269M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$255M |
Top Sells
| 1 |
Baidu
BIDU
|
+$1.17B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$727M |
| 3 |
Pinduoduo
PDD
|
+$599M |
| 4 |
AbbVie
ABBV
|
+$564M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$483M |
Sector Composition
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.2% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Consumer Staples | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Vital Energy
VTLE
$635M
| $4.11M | 0.01% |
136,673
-6,857
| -5% | -$206K |
|
1777
RF Industries
RFIL
$79.1M
| $4.1M | 0.01% |
677,251
-89,318
| -12% | -$541K |
|
|
PLYM
1778
Plymouth Industrial REIT
PLYM
$980M
| $4.1M | 0.01% |
243,270
-155,722
| -39% | -$2.62M |
|
1779
Urban Edge Properties
UE
$2.66B
| $4.09M | 0.01% |
+247,400
| New | +$4.09M |
|
|
IEC
1780
DELISTED
IEC Electronics Corp.
IEC
| $4.08M | 0.01% |
338,912
-10,700
| -3% | -$129K |
|
1781
Pitney Bowes
PBI
$1.96B
| $4.08M | 0.01% |
495,100
-300,900
| -38% | -$2.48M |
|
1782
Franklin Covey
FC
$240M
| $4.08M | 0.01% |
144,203
-87,201
| -38% | -$2.47M |
|
|
NP
1783
DELISTED
Neenah, Inc. Common Stock
NP
| $4.07M | 0.01% |
79,200
+74,400
| +1,550% | +$3.82M |
|
|
AERI
1784
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $4.07M | 0.01% |
227,510
-59,000
| -21% | -$1.05M |
|
|
LBC
1785
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $4.05M | 0.01% |
342,268
+50,200
| +17% | +$594K |
|
1786
Orion Group Holdings
ORN
$299M
| $4.04M | 0.01% |
665,697
-153,666
| -19% | -$933K |
|
|
ETRN
1787
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $4.04M | 0.01% |
+495,222
| New | +$4.04M |
|
|
CBAY
1788
DELISTED
Cymabay Therapeutics
CBAY
| $4.04M | 0.01% |
890,163
+480,443
| +117% | +$2.18M |
|
|
VIOT
1789
Viomi Technology
VIOT
$241M
| $4.04M | 0.01% |
448,932
-171,700
| -28% | -$1.55M |
|
1790
Surgery Partners
SGRY
$2.8B
| $4.04M | 0.01% |
91,242
-101,300
| -53% | -$4.48M |
|
1791
Veritone
VERI
$206M
| $4.02M | 0.01% |
167,600
-204,900
| -55% | -$4.91M |
|
|
FNHC
1792
DELISTED
FedNat Holding Company Common Stock
FNHC
| $4.02M | 0.01% |
867,207
+14,819
| +2% | +$68.6K |
|
1793
First Hawaiian
FHB
$3.19B
| $4.01M | 0.01% |
146,500
-5,100
| -3% | -$140K |
|
1794
Madrigal Pharmaceuticals
MDGL
$9.63B
| $4.01M | 0.01% |
34,282
+249
| +0.7% | +$29.1K |
|
|
IMBI
1795
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $4.01M | 0.01% |
517,258
+15,900
| +3% | +$123K |
|
1796
Rogers Corp
ROG
$1.47B
| $3.99M | 0.01% |
21,174
-23,387
| -52% | -$4.4M |
|
1797
United-Guardian
UG
$35.8M
| $3.97M | ﹤0.01% |
262,263
-5,860
| -2% | -$88.8K |
|
1798
CEMIG Preferred Shares
CIG
$5.84B
| $3.97M | ﹤0.01% |
3,294,227
+2,594,069
| +370% | +$3.13M |
|
|
ACOR
1799
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $3.97M | ﹤0.01% |
40,720
+6,676
| +20% | +$650K |
|
1800
KalVista Pharmaceuticals
KALV
$708M
| $3.94M | ﹤0.01% |
153,428
+104,000
| +210% | +$2.67M |
|